Page last updated: 2024-10-24

chloroquine and Pterygium

chloroquine has been researched along with Pterygium in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Pterygium: An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Obikili, AG1

Other Studies

1 other study available for chloroquine and Pterygium

ArticleYear
A type of macular degeneration in adult Nigerians; a possible role of chloroquine.
    East African medical journal, 1990, Volume: 67, Issue:9

    Topics: Adult; Chloroquine; Female; Humans; Macular Degeneration; Malaria; Male; Nigeria; Pterygium; Retrosp

1990